TY  - JOUR
AU  - Lopez-Carmona, M D
AU  - Plaza-Seron, M C
AU  - Vargas-Candela, A
AU  - Tinahones, F J
AU  - Gomez-Huelgas, Ricardo
AU  - Bernal-Lopez, M R
PY  - 2017
DO  - 10.1186/s13098-017-0253-x
SN  - 1758-5996
UR  - http://hdl.handle.net/10668/11426
T2  - Diabetology & metabolic syndrome
AB  - CD36 is a scavenger receptor located on monocytes which is involved in foam cell transformation. To evaluate CD36 expression under different glycemic states in both healthy subjects and in atherosclerotic patients. In order to evaluate the possible...
LA  - en
PB  - BioMed Central
KW  - Atherosclerosis
KW  - CD36 receptor
KW  - Human clinical
KW  - Monocytes
KW  - Type 2 diabetes
KW  - Insulin
KW  - Monocytes
KW  - Glucose
KW  - CD36 Antigens
KW  - Foam cells
KW  - Glycated proteins
KW  - Healthy Volunteers
KW  - Prediabetic state
KW  - Hyperglycemia
KW  - Diabetes mellitus
KW  - Insulin, regular, human
TI  - CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.
TY  - research article
VL  - 9
ER  -